In vitro activity of Bulgarian propolis against 94 clinical isolates of anaerobic bacteria

被引:44
作者
Boyanova, Lyudmila
Kolarov, Rossen
Gergova, Galina
Mitova, Ivan
机构
[1] Med Univ Sofia, Dept Microbiol, Sofia 1431, Bulgaria
[2] Univ Sofia, Hosp Maxillofacial Surg, BU-1126 Sofia, Bulgaria
关键词
anaerobic; bacteria; propolis; inhibition; activity;
D O I
10.1016/j.anaerobe.2006.06.001
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The aim was to evaluate the effect of 30% ethanolic extract of Bulgarian propolis on 94 clinical anaerobic strains. The strains were tested by both agar-well diffusion (wells, 7 mm diameter) and disk-diffusion methods. Only 15% of Clostridium-, 3.3% of other Gram-positive- and 9.1% of Gram-negative anaerobic strains were not inhibited by 30 mu L propolis extract per well. Propolis extract was more active than the ethanol (P < 0.001). By 30 mu L extract per well, mean inhibitory diameters of the clostridia, other Gram-positive- and Gram-negative anaerobes were 11.5, 13.1, and 11.3 mm, and those by 90 mu L were 16, 18.1 and 15.4 mm, respectively. Mean inhibitory diameters of all strains by 30 and 90 mu L ethanol were only 8.4 and 9.5 mm. By 30 mu L propolis extract per well, inhibitory diameters of 15 mm or more were more common in Gram-positive (32%) than in Gram-negative bacteria.(13.6%, P < 0.05). Moist propolis disks inhibited more strains (89.4%) than dried disks (68.1%, P < 0.001). Most (81.8%) Bacteroides fragilis group strains and 75% of clostridial strains were inhibited by moist EEP disks. Conclusion: Bulgarian propolis was active against most anaerobic strains of different general In addition to oral pathogens, an activity of propolis against Clostridium, Bacteroides and Propionibacterium species was observed. The results could motivate a higher medical interest and further trials for evaluating the use of bee glue for prophylaxis or treatment of some anaerobic infections such as oral, skin and wound diseases. (c) 2006 Elsevier Ltd. All rights reserved.
引用
收藏
页码:173 / 177
页数:5
相关论文
共 16 条
[1]   Recent trends and important developments in propolis research [J].
Bankova, V .
EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2005, 2 (01) :29-32
[2]  
Bankova VS, 2000, APIDOLOGIE, V31, P3, DOI 10.1051/apido:2000102
[3]   Review of the biological properties and toxicity of bee propolis (propolis) [J].
Burdock, GA .
FOOD AND CHEMICAL TOXICOLOGY, 1998, 36 (04) :347-363
[4]   In vitro antimicrobial activity of propolis dry extract [J].
Drago, L ;
Mombelli, B ;
De Vecchi, E ;
Fassina, MC ;
Tocalli, L ;
Gismondo, MR .
JOURNAL OF CHEMOTHERAPY, 2000, 12 (05) :390-395
[5]   Propolis:: anti-Staphylococcus aureus activity and synergism with antimicrobial drugs [J].
Fernandes, A ;
Balestrin, EC ;
Elaine, J ;
Betoni, C ;
Orsi, RD ;
da Cunha, MDRD ;
Montelli, AC .
MEMORIAS DO INSTITUTO OSWALDO CRUZ, 2005, 100 (05) :563-566
[6]   Comparison of propolis skin cream to silver sulfadiazine: A naturopathic alternative to antibiotics in treatment of minor burns [J].
Gregory, SR ;
Piccolo, N ;
Piccolo, MT ;
Piccolo, MS ;
Heggers, JP .
JOURNAL OF ALTERNATIVE AND COMPLEMENTARY MEDICINE, 2002, 8 (01) :77-83
[7]  
Hegazi AG, 2000, Z NATURFORSCH C, V55, P70
[8]  
Jousimies-Somer HR, 2002, WADSWORTH ANAEROBIC
[9]   In vitro antimicrobial activity of propolis and Arnica montana against oral pathogens [J].
Koo, H ;
Gomes, BPFA ;
Rosalen, PL ;
Ambrosano, GMB ;
Park, YK ;
Cury, JA .
ARCHIVES OF ORAL BIOLOGY, 2000, 45 (02) :141-148
[10]   Herbal medicines for treatment of bacterial infections: a review of controlled clinical trials [J].
Martin, KW ;
Ernst, E .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2003, 51 (02) :241-246